Late apoptotic effects after treatment with <sup>177</sup> Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model
The study present similarities and differences in molecular response between the groups of different <sup>177</sup>Lu-octreotate treatments. The results may have impact on the optimization of therapy in the future.
Authors
- Mikael Elvborn (ORCID: https://orcid.org/0000-0002-5470-1377)
- Khalil Helou (ORCID: https://orcid.org/0000-0002-7847-4391)
- Daniella Pettersson
- Johan K. E. Spetz (ORCID: https://orcid.org/0000-0002-5216-9786)
- Eva B. Forssell-Aronsson (ORCID: https://orcid.org/0000-0002-7558-4368)
- Nishte Rassol
- Emman Shubbar
Institutions
- National Academy of Medicine (US)
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- International Journal of Radiation Biology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1080/09553002.2025.2542318
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancerfonden
- Vetenskapsrådet
- Stiftelsen Assar Gabrielssons Fond
- Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer
- Strålsäkerhetsmyndigheten